Form 4: BlackRock BMEZ Portfolio Manager Sells Shares

BlackRock Health Sciences Term Trust portfolio manager, Xie H Erin, reported the sale of common stock following the vesting and conversion of phantom shares.

Summary

• Xie H Erin, a Portfolio Manager for BlackRock Health Sciences Term Trust (BMEZ), reported transactions on January 30, 2026.
• Acquired 25,676.2744 shares of common stock through the conversion of phantom shares.
• Disposed of 25,676.2744 shares of common stock at a price of $15.21 per share.
• Beneficial ownership of common stock following these reported transactions is 0 shares.
• Acquired 17,560.4931 new phantom shares, which vest in equal installments on each of the first three anniversaries of the award.
• Exercised 8,915.3466 phantom shares from a January 31, 2025 grant, leaving 17,830.6932 phantom shares remaining from that grant.
• Exercised 8,861.5513 phantom shares from a January 31, 2024 grant, leaving 8,861.5513 phantom shares remaining from that grant.
• Exercised 7,899.3765 phantom shares from a January 31, 2023 grant, resulting in 0 phantom shares remaining from that grant.
• Phantom shares are the economic equivalent of one share of common stock and become payable in cash upon vesting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine insider transaction related to compensation and vesting, which typically has a neutral impact on market sentiment as it is a scheduled event rather than a discretionary sale.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider transactions, such as those reported on a Form 4, are routine disclosures related to executive compensation and equity vesting. While they can sometimes offer insights into management's perception of the company's value, this specific transaction appears to be part of a pre-arranged vesting and sale plan, common across the financial industry for portfolio managers.

Stakeholder Impact

• Shareholders may note the sale of common stock by a portfolio manager, but given its nature as a vesting-related transaction, the direct impact on shareholder confidence is likely minimal.

Key Dates

Recommendation

This Form 4 details a routine insider transaction involving the vesting and subsequent sale of common stock by a portfolio manager, likely as part of a pre-established compensation plan. Such transactions are generally not indicative of a change in the company's fundamental outlook or performance and therefore do not warrant a change in investment recommendation.

Keywords

BlackRock, BMEZ, insider transaction, Form 4, stock sale, phantom shares, portfolio manager, equity compensation, health sciences